SAB Biotherapeutics, Inc. (SABS)

Price & Market Data

Price: $3.70

Daily Change: -$0.11 / 2.97%

Daily Range: $3.70 - $3.97

Market Cap: $298,209,984

Daily Volume: 326,176

Performance Metrics

1 Week: 2.86%

1 Month: 2.60%

3 Months: 2.60%

6 Months: 2.60%

1 Year: 131.0%

YTD: 4.50%

About SAB Biotherapeutics, Inc. (SABS)

Stay informed about SAB Biotherapeutics, Inc. (SABS). Price: 3.70, daily change: -$0.11 / 2.97%. Market cap: 298,209,984. Detailed performance for all key periods.

Company Details

Employees: 86

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.

Selected stocks

Integra Resources Corp. (ITRG)

Comp En De Mn Cemig (CIG-C)

Jupiter Neurosciences, Inc. (JUNS)

The Oncology Institute, Inc. (TOI)

The Real Brokerage, Inc. (REAX)